胃食管反流病与功能性消化不良、肠易激综合征症状重叠的研究

目的探讨胃食管反流病（GERD）重叠功能性消化不良（FD）、肠易激综合征（IBS）症状的发生率，分析糜烂性食管炎（EE）和非糜烂性反流病（NERD）亚型患者重叠FD、IBS症状发生率的异同。方法通过胃镜及24h食管pH监测，将147例GERD患者区分为EE47例、病理性酸反流[NERDpH（＋）]42例和生理性酸反流[NERDpH（-）]58例。根据罗马Ⅱ诊断标准对患者重叠FD、IBS症状的情况进行问卷调查。采用《检验比较不同组间重叠症状发生率。结果147例GERD患者中重叠FD症状54例（36．7％），重叠IBS症状19例（12．9％），其中同时重叠FD、IBS症状10例（6．8％）。EE及NERD组重叠FD症状者分别为11例（23．4％）及43例（43．0％），差异有统计学意义（P〈0．05）。EE及NERDpH（＋）组重叠FD症状者分别为n例（23．4％）及13例（31．O％），差异无统计学意义（P〉0．05）。NERDpH（＋）组及pH（-）组重叠FD症状者分别为13例（31．0％）及30例（51．7％），差异有统计学意义（P〈0．05）。EE及NERD组重叠IBS症状者分别为6例（12．8％）及13例（占13．0％），差异无统计学意义（P〉0．05）。NERDpH（＋）组及pH（-）组重叠IBS症状者分别为4例（9．5％）及9例（15．5％），差异无统计学意义（P〉0．05）。结论部分GERD患者重叠FD、IBS症状。无异常食管酸暴露的烧心患者易合并FD症状。     

胃食管反流病与功能性肠道疾病的重叠及其相关因素

目的: 探讨胃食管反流病(gastro-oesophageal reflux disease, GERD)与功能性肠道疾病的重叠情况及其相关因素.方法: 2008-07/2008-12我院消化科门诊收治具有反酸、反食、烧心、胸骨后疼痛等症状的患者232例, 对其进行反流性疾病问卷调查(reflux disease questionnaire, RDQ), 以症状积分(S c)≥12为症状性胃食管反流标准. 将患者分为GERD组(Sc≥12)和对照组(Sc<12)2组, 记录患者的身高、体质量、吸烟史、饮酒史. 按照罗马Ⅲ诊断标准筛选功能性肠道疾病患者, 包括肠易激综合征(irritable bowel syndrome, IBS)、功能性腹泻(functional diarrhea, FD)、功能性便秘(functiona constipation, FC)、功能性腹胀(functional bloating, FB)等. 采用t检验、χ2检验、Logistic回归分析重叠率及其相关因素.结果: GERD与IBS, FD, FC, FB的重叠率分别为29.1%, 15.2%, 10.6%, 2.0%, 均高于对照组(11.1%, 3.7%, 9.9%, 1.2%). GERD组与对照组相比IBS重叠率有显著统计学差异( P<0.05), 2组间FD, FC, FB的重叠率无显著统计学差异.GERD症状积分与发生功能性肠道疾病的重叠有相关性( P<0.01), 年龄、性别、体质量指数、吸烟史、饮酒史与发生功能性肠道疾病的重叠无相关性.结论: GERD与IBS、FD、FC、FB均有一定的重叠, 但与IBS的重叠率最高且明显高于一般人群. GERD患者的症状积分越高, 与功能性肠道疾病发生重叠的几率越大.     

功能性消化不良重叠肠易激综合征患者的消化道症状和生活质量特点

背景：流行病学研究表明，功能性消化不良（FD）与肠易激综合征（IBS）的症状存在相当多的重叠。目的：探讨FD重叠IBS患者的消化道症状和生活质量特点。方法：选取济南市三家医院同期FD重叠IBS以及单纯FD、IBS患者共1410例，行FD和（或）IBS症状以及生活质量问卷调查并评分，对结果进行统计分析。结果：FD重叠IBS组男女比例为1：1．8，其上、下消化道症状分别较单纯FD和IBS组严重fP〈0．01），生活质量受到影响。结论：FD与IBS症状重叠提示两者可能具有共同的神经胃肠病学基础。女性患者多见且消化道症状严重，可能与胃肠道敏感性增高有关。     

以罗马Ⅲ标准为基础的功能性消化不良临床研究

背景:功能性消化不良(FD)发病率较高,自2006年罗马Ⅲ标准发布以后,中国大陆地区关于FD的临床研究并不多见。目的:探讨以罗马Ⅲ标准为基础的FD的临床特征。方法:选取2009年4月～2010年4月上海长海医院收治的符合罗马Ⅲ标准的100例FD患者,对其一般情况、治疗效果、重叠症相关因素等进行分析。结果:100例FD患者以女性多见,平均发病年龄(40.9±12.3)岁。根据症状分型,餐后不适综合征(PDS)患者30例,上腹痛综合征(EPS)22例,混合型48例。行对症治疗后,71.0%的FD患者症状消失。随着体重指数(BMI)升高,FD患者的消化不良症状呈加重趋势,但差异无统计学意义(P=0.08)。38.0%的FD患者重叠肠易激综合征(IBS),22.0%重叠胃食管反流病(GERD)。FD重叠IBS患者的餐后胞胀不适发生率明显高于单独FD患者(P=0.02)。结论:对症治疗可使多数FD患者的症状改善,BMI可能与FD症状有关。FD重叠IBS患者的餐后饱胀不适发生率显著高于单独FD患者。     

功能性胃肠病与胃食管反流病重叠发病的研究

目的 调查功能性胃肠病(FGIDs)患者重叠胃食管反流病(GERD)的发病率.方法 收集2006年8～10月解放军总医院消化科门诊FGIDs患者492例,调查其重叠GERD的情况.包括功能性消化不良(FD)、肠易激综合征(IBS)、慢性功能性便秘(CC)、功能性腹泻(F-D)、功能性腹胀(FB)和功能性嗳气(BD).FGIDs的诊断参照罗马Ⅲ标准;GERD的诊断按照耐信(RDQ)量表,以烧心、胸骨后疼痛感、反酸和反食症状的程度和频度积分≥12分作为判断标准.结果 492例FGIDs患者重叠GERD者达73例,重叠率为14.84%.重叠GERD组和无重叠组相比.患者的性别、年龄、病程、居住地、吸烟史及饮酒史差异无统计学意义(P>0.05).重叠率最高的3种FGIDs依次为FD、CC和IBS.FD患者重叠GERD者21.32%;CC患者重叠GERD者19.35%;12.55%的IBS患者重叠GERD.重叠率最低的FGIDs为BD,重叠率7.69%.302例单一FGIDs患者,重叠GERD者37例,重叠率为12.25%;190例重叠FGIDs患者,重叠GERD者36例,重叠率为18.95%.两组GERD重叠率比较差异有统计学意义(P<0.05).重叠GERD最多的单一FGIDs为FD,重叠率21.62%;其次为F-D和BD,单一FB未见重叠GERD患者.结论 按照罗马Ⅲ诊断标准,FGIDs患者重叠GERD常见.重叠率最高的3种FGIDs依次为FD、CC和IBS,重叠率最低的FGIDs为BD.重叠GERD最多的单一FGIDs为FD,其次为F-D和BD,单一FB未见重叠GERD患者.重叠FGIDs组GERD的重叠率明显高于单一FGIDs组.     

功能性消化不良患者十二指肠嗜酸性粒细胞、嗜铬粒蛋白A阳性细胞数量变化及其意义

背景:流行病学资料显示功能性消化不良(FD)与肠易激综合征(IBS)症状重叠相当常见。研究发现FD患者十二指肠嗜酸性粒细胞(EOS)数量增多,而IBS患者则存在十二指肠嗜铬粒蛋白A(Cg A)阳性细胞密度降低。目的:探讨单纯FD和FD重叠腹泻型IBS(IBS-D)患者十二指肠EOS、Cg A阳性细胞数量的变化及其意义。方法:纳入2014年8月—2015年3月就诊于福建医科大学附属第一医院、符合罗马Ⅲ标准的新诊断FD患者和FD-IBS-D重叠患者,取十二指肠球部活检组织,分别以HE染色和免疫组化染色检测、计数EOS、Cg A阳性细胞,并分析其与临床症状的相关性。结果:28例FD患者和12例FD-IBS-D重叠患者纳入研究。FD-IBS-D组十二指肠球部EOS数量显著多于FD组[(43.83±7.34)/5HPF对(22.90±8.93)/5HPF,P0.05],Cg A阳性细胞数量显著少于FD组[(13.03±5.87)/HPF对(19.85±9.18)/HPF,P0.05]。Spearman相关系数分析显示十二指肠EOS数量与腹痛/腹部不适、腹泻等下消化道症状呈显著正相关,Cg A阳性细胞数量与上、下消化道症状均无明显相关性。结论:与单纯FD患者相比,FD-IBS-D重叠患者十二指肠球部EOS数量明显增多,Cg A阳性细胞数量明显减少,可能反映了两者间临床症状的差异。     

惠州地区胃食管反流病与肠易激综合征重叠的特征

目的 探讨惠州地区胃食管反流病（GERD）重叠肠易激综合征（IBS）的症状特征.方法 采用整群、分层、随机抽样的方法,收集到61例GERD症状人群,其中12例（19.7％） GERD重叠IBS患者、49例单纯GERD患者,记录其人口统计学资料以及症状严重程度,对结果进行统计分析.结果 GERD重叠IBS组男女比例为1：1.4,其症状较单纯GERD组严重（P＜0.05）.结论 GERD与IBS的重叠现象多见,患者多为女性,且症状更严重.     

肠易激综合征重叠症的研究进展

肠易激综合征(IBS)是一种常见的以反复发作的腹痛或腹部不适伴排便频率或粪便性状改变为特征的功能性肠病,可单独发生,亦可与其他疾病并存。IBS除可与胃肠道疾病如胃食管反流病(GERD)、功能性消化不良(FD)、炎症性肠病(IBD)、显微镜肠炎(MC)、乳糜泻等重叠外,还可与非胃肠道疾病如焦虑症、哮喘等重叠。本文从流行病学和病理生理学角度对IBS重叠症作一综述。     

有和无重叠症状的肠易激综合征患者生活质量及精神心理状况比较研究

目的 调查有和无重叠症状的肠易激综合征(IBS)患者的生活质量、精神心理状况,分析有重叠症状IBS患者生活质量特点,探讨影响其生活质量的主要凶素及重叠症状产生的可能原因.方法 对2007年10月至2008年4月在我院消化科门诊就诊的、符合罗马Ⅲ诊断标准的76例IBS患者建立健康档案,采用消化道症状调查表、汉化版简明健康调查量表(SF-36)、焦虑自评量表(SAS)和抑郁自评量表(SDS)进行问卷调查.根据问卷调查结果将其分为有重叠症状组(食管、胃、十二指肠和肛门直肠症状)和无重叠症状组,分析比较两组患者生活质量和精神心理状况,并对结果进行统计学分析.结果 有重叠症状组IBS患者生活质量较无重叠症状组降低,合并焦虑抑郁状态的比例高于无重叠症状组(P＜0.05).结论 伴随重叠症状的IBS患者生活质量受到影响,不良精神心理因素可能是其生活质量主要影响因素及重叠症状产生的原因.     

功能性胃肠病烧心症状病机分析

[目的]探讨功能性胃肠病（FGIDs）烧心症状的中医证候分布规律、病机及其症状重叠与复发。[方法]构建证候四诊合参数据库，SPSS 8．0统计软件包分析。[结果]烧心症状分布与肝郁关系最为密切，其次与脾虚相关，再次为肾；33．3％的胃食管反流病（GERD）并肠易激综合征（IBS）症状重叠，47．1％的功能性消化不良（FD）患者伴有IBS症状重叠，97．6％的IBS患者伴有FD症状重叠；烧心治疗停药6个月后复发41例。[结论]以实证、虚实夹杂居多，病机关键是肝气横逆郁滞，脾胃虚弱；FGIDs患者症状重叠性较高，烧心复发率较高；其机制除了与酸相关外，内脏痛觉过敏等因素与烧心的产生亦有关。     

Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia

Epidemiological studies suggest considerable overlap between functional dyspepsia (FD) and irritable bowel syndrome (IBS). AIM: The aim of the present study was to investigate whether coexisting IBS is also associated with symptom pattern or pathophysiology in FD. METHODS: In 309 consecutive FD patients (207 women, age 42 +/- 0.8 yr), questionnaires were used to assess the dyspepsia symptom pattern and the Rome II criteria for IBS. The overall symptom severity was calculated adding the severity score (0-3, 0 = absent, 3 = severe) of eight dyspepsia symptoms. All patients underwent Helicobacter pylori testing, gastric barostat to determine sensitivity to distention and accommodation to a meal, and gastric emptying breath test. RESULTS: Fifty-four percent of the patients had FD alone, whereas 46% had FD + IBS. FD + IBS patients were more likely to be female (75%vs 60%, p < 0.01) and to have a greater weight loss (5.4 +/- 0.6 vs 3.5 +/- 0.4 kg, p < 0.05). Coexisting IBS did not increase the risk of having any of the dyspeptic symptoms but the overall symptom severity was significantly higher in FD + IBS (12.4 +/- 0.4 vs 9.8 +/- 0.3, p < 0.01). FD + IBS patients had a lower threshold for first perception (2.9 +/- 0.3 vs 3.8 +/- 0.3 mmHg, p < 0.05) and for discomfort (7.9 +/- 0.4 vs 9.5 +/- 0.5 mmHg, p < 0.05) and a greater prevalence of hypersensitivity to gastric distention (44%vs 28%, p < 0.05). Gastric emptying, accommodation to a meal, and prevalence of H. pylori infection did not differ in the two groups. CONCLUSION: About half of the FD patients fulfill the Rome II criteria for IBS. FD + IBS is more prevalent in female patients and is associated with a higher weight loss, with greater overall symptom severity, and with hypersensitivity to distention.     

Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome

The importance of personality traits in nonulcer dyspepsia and irritable bowel syndrome is a controversial issue. We wished to assess the distribution of abnormal personality traits in nonulcer dyspepsia and the irritable bowel syndrome, define any relation among personality and symptoms, and determine whether personality factors discriminate among patients with functional, psychiatric, or organic gastrointestinal diseases. Patients with nonulcer dyspepsia (n = 31), irritable bowel syndrome (n = 67), organic gastrointestinal disease (n = 64), somatoform disorder (n = 36) and healthy controls (n = 128) were studied. Before diagnostic evaluation by an independent physician, all patients completed the Minnesota Multiphasic Personality Inventory and a symptom questionnaire. Symptom scores for abdominal pain and the Manning criteria, which is considered to be diagnostic for the irritable bowel syndrome, were evaluated. Personality scales in patients with nonulcer dyspepsia, irritable bowel syndrome, and organic disease were very similar. However, patients in the other groups differed from somatoform disorder on nearly all scales. In nonulcer dyspepsia, irritable bowel syndrome, and organic disease, hypochondriasis weakly correlated with pain. Subgroups of irritable bowel syndrome patients with predominant constipation and those with predominant diarrhea had similar personality traits, although hypomania was minimally increased in constipation. Patients who fulfilled the Manning criteria for irritable bowel syndrome had more psychological distress than those who did not. The Minnesota Multiphasic Personality Inventory correctly classified somatoform disorder and health 81% and 75% of the time, respectively, but it classified nonulcer dyspepsia and irritable bowel syndrome correctly in only 32% and 34% of cases. Our results suggest that psychopathology may not be the major explanation for functional gastrointestinal disorders.     

Funktionelle Magen-Darm-Erkrankungen

Functional dyspepsia (FD) and irritable bowel syndrome (IBS) are the most important functional gastrointestinal diseases (FGID), and both affect about 5–15?% of the German population. The patients’ symptoms are caused by disturbances of gastrointestinal (GI) motility, secretion and sensitivity. Central processing of visceral afferences is disturbed, and the course of the disease and individual symptom perception are influenced by psychosocial factors. Diagnosis of FD and IBS is based on a compatible symptom pattern, absence of alarm symptoms and exclusion of relevant differential diagnoses. The diagnosis of FD requires a normal upper GI endoscopy. Current German guidelines also demand a normal colonoscopy for diagnosis of IBS. Basic therapeutic measures include explanation of the nature of the disease and its harmlessness quo ad vitam . Individual trigger factors should be identified and eliminated if possible. Drug therapy of persisting complaints is guided by the dominant symptom.     

精神心理因素在肠易激综合征和功能性消化不良重叠症中的作用

目的探讨精神心理因素在肠易激综合征和功能性消化不良重叠症中的作用。方法对38例肠易激综合征（iBS）与功能性消化不良（FD）重叠症患者采用汉密尔顿焦虑量表（HAMA）14项和汉密尔顿抑郁量表（HAMD）17项版本进行心理测评,并将调查对象分为体力劳动组和非体力劳动组,比较分析各组评分的特点。结果女性FD与IBS重叠症患者焦虑抑郁障碍发病率较男性无显著性差异（68．2％vs75．0％,X2=0．21,P〉0．05）,非体力劳动者FD与IBS重叠症患者焦虑抑郁障碍发病率较体力劳动者显著升高（85．2％vs36．4％,X2=9．09,P〈0．005）。结论非体力劳动者FD与IBS重叠症患者合并精神心理压力可能通过增加内脏敏感性使FD与IBS重叠症发病率更高,提示心理治疗可能有助于治疗FD与IBS重瞢症。     

Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease

OBJECTIVE: Previous studies have reported an overlap between gastroesophageal reflux symptoms, functional dyspepsia (FD) and irritable bowel syndrome (IBS). The aim of this study was to investigate the prevalence of FD and IBS in gastroesophageal reflux disease (GERD) and the effect on health-related quality of life (HRQoL). MATERIAL AND METHODS: FD and IBS prevalence and HRQoL were assessed by means of questionnaires in 215 referred and 48 non-referred (non-care-seeking) GERD patients, proven with 24-h pH-metry. HRQoL in 131 matched controls was used for comparison. RESULTS: In this group of GERD patients 25% had FD (Dutch general population 13-14%), 35% had IBS (Dutch general population 0.6-6%) and 5% had both FD and IBS. Only 35% had neither FD nor IBS. Among referred GERD patients, the prevalence of FD and IBS was higher (p=0.002 versus non-referred). Compared with controls, GERD patients without FD/IBS had lower HRQoL scores on only one of the nine SF-36 subscales (p相似文献   

Gender difference in the overlap of irritable bowel syndrome and functional dyspepsia: a prospective nationwide multicenter study in Korea

Journal of Gastroenterology - The overlap between functional dyspepsia (FD) and irritable bowel syndrome (IBS) is associated with more severe gastrointestinal (GI) symptoms and lower quality of...     

Funktionelle Dyspepsie und funktionelle Ösophaguserkrankungen

Functional disorders of the esophagus, stomach or bowel represent a large spectrum of digestive disorders characterized by defined symptoms specific to the gastrointestinal tract (GI). In patients with functional dyspepsia (FD) pain, early satiety or fullness are the key symptoms. Patients with functional disorders of the esophagus are typically affected by heartburn or dysphagia. A functional disorder is diagnosed if relevant chronic or relapsing symptoms exist and a diagnostic work-up utilising routine clinical tests does not reveal a cause for the symptoms. It is important to note that symptoms of FD and functional symptoms of the esophagus frequently coexist with symptoms of irritable bowel syndrome (IBS). This may suggest that there is a common pathophysiological basis. Overlap typically occurs in patients with more severe impairment from symptoms. It is remarkable that in these patients there are significant psychiatric comorbidities which may suggest that central nervous system (CNS) factors play a role for symptom manifestation. While the underlying pathophysiology is as yet not fully explained there is sufficient evidence to assume that alterations of sensory and motor function are critical for the manifestation of symptoms. More recently the role of minimal mucosal and systemic inflammation has been discovered. Alterations of the gastrointestinal microbiome are probably key for the inflammatory changes. While much attention is given to stool microbiome it is more likely than not that the mucosal microbiome is critical instead of the composition of stool. Technical developments such as the Brisbane biopsy device in combination with the refinement of extraction and sequencing methods might be critical for the future to gain insights into this new and emerging field.     

Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters

BACKGROUND: Our aim was to assess the relationship between gastric motor and sensory function and symptom patterns in community subjects and patients with functional dyspepsia (FD) or irritable bowel syndrome (IBS). METHODS: We recruited 291 asymptomatic blood donors, 151 symptomatic blood donors (recurrent abdominal pain or discomfort), and 40 patients with FD or IBS. Abdominal symptoms were assessed using the bowel disease questionnaire (BDQ) and, in addition, the most bothersome symptom complex identified (dysmotility-type, ulcer-type dyspepsia, or IBS). Gastric emptying time (GET (t(1/2), min)) was measured by (13)C-octanoic breath test and a nutrient challenge performed. Twenty randomly selected asymptomatic blood donors, 48 symptomatic blood donors (30 FD, 18 IBS), and 40 patients (23 FD, 17 IBS) had additional function testing. RESULTS: GET (t(1/2)) was significantly (p<0.05) longer in blood donors with FD symptoms (99 (6) min) and FD patients (110 (12) min) compared with asymptomatic controls (76.7 (7) min), but was not significant in IBS blood donors or patients. Overall, 25 of 48 blood donors with symptoms and 18 of 40 patients had slow gastric emptying. GET was most delayed in subjects with predominantly dysmotility-type symptoms (167 (36) min v controls; p<0.01). Symptom intensities after a nutrient challenge were significantly higher in FD patients and symptomatic blood donors compared with asymptomatic controls; 14 of 48 blood donors with symptoms and 16 of 40 patients had a symptom response to the nutrient challenge exceeding the response (mean (2SD)) of healthy asymptomatic controls. CONCLUSION: Gastric emptying and the global symptom response to a standardised nutrient challenge are abnormal in population based (non-health care seeking) subjects with dyspepsia.     

Asia-Pacific guidelines for managing functional dyspepsia overlapping with other gastrointestinal symptoms

Contemporary systems for the diagnosis and management gastrointestinal symptoms not attributable to organic diseases (Functional GI Disorders, FGID, now renamed Disorders of Gut-Brain Interaction, DGBI) seek to categorize patients into narrowly defined symptom-based sub-classes to enable targeted treatment of patient cohorts with similar underlying putative pathophysiology. However, an overlap of symptom categories frequently occurs and has a negative impact on treatment outcomes. There is a lack of guidance on their management. An Asian Pacific Association of Gastroenterology (APAGE) working group was set up to develop clinical practice guidelines for management of patients with functional dyspepsia (FD) who have an overlap with another functional gastrointestinal disorder: FD with gastroesophageal reflux (FD-GERD), epigastric pain syndrome with irritable bowel syndrome (EPS-IBS), postprandial distress syndrome with IBS (PDS-IBS), and FD-Constipation. We identified putative pathophysiology to provide a basis for treatment recommendations. A management algorithm is presented to guide primary and secondary care clinicians.     

Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Patients with Functional Dyspepsia

Digestive Diseases and Sciences - Antimicrobial therapy improves symptoms in patients with irritable bowel syndrome (IBS), but the efficacy in functional dyspepsia (FD) is largely unknown. While FD...